Larissa leads the way in treating human parainfluenza virus
Pre-clinical trials are being planned on a treatment for human parainfluenza virus discovered by the Institute for Glycomics. This treatment...
Pre-clinical trials are being planned on a treatment for human parainfluenza virus discovered by the Institute for Glycomics. This treatment...
The Institute for Glycomics has been awarded two National Health and Medical Research Council Investigator Grants.
Griffith's Institute for Glycomics has partnered with China Grand Pharma’s new Australian company Grand Medical Ltd to develop a drug to treat millions of people with respiratory illnesses.
Gold Coast research has made a giant leap forward in understanding one of the most common causes of respiratory infections worldwide.